From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention.
1. InspireMD inks Chile distribution deal
InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime Embolic Protection System (EPS). The MGuard Prime EPS treats acute coronary syndromes like acute myocardial infarctions.
2. Medacta launches MiniMed hip stem
Medacta has launched its MiniMAX Hip System in the U.S., according to an Oct. 12 press release. MiniMAX is an anatomical cementless stem that is engineered to provide enhanced fit and fill in the metaphyseal femur. It follows the natural shape of the femoral canal for minimally-invasive anterior and posterior hip replacement procedures.
3. Esaote launches MyLab 9 ultrasound
Esaote announced in an Oct. 13 press release that it has launched its MyLab 9 ultrasound platform. MyLab 9 has smart upgradability, remote serviceability, long-term maintenance options and transducer compatibility.